Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity
We have previously shown that predominant expression of key inflammatory cytokines and chemokines at autoimmune sites or tumor sites induces loss of B cells tolerance, resulting in autoantibody production against the dominant cytokine/chemokine that is largely expressed at these sites. These autoant...
Main Author: | Nathan Karin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00623/full |
Similar Items
-
Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis
by: Krishnadas Madhu, et al.
Published: (2019-01-01) -
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Dhaiban S, et al.
Published: (2020-09-01) -
Interrelation of Diet, Gut Microbiome, and Autoantibody Production
by: Ioanna Petta, et al.
Published: (2018-03-01) -
Elucidating the mechanisms of disease-triggering myelin-specific autoantibodies
by: Strauß, Judith
Published: (2019) -
Anti-inflammatory effect and mechanisms of Huangqi glycoprotein in treating experimental autoimmune encephalomyelitis
by: Huiyu Zhang, et al.
Published: (2017-12-01)